• Home>
  • Stocks>
  • Dishman Carbogen Amcis Ltd Share Price
Dishman Carbogen Amcis Ltd share price logo

Dishman Carbogen Amcis Ltd Share Price

(DCAL)

Small Cap

Healthcare Sector

Check the latest share price of Dishman Carbogen Amcis Ltd, details on performance, fundamentals, analyst ratings, peer comparison, financials, company news, analysis, and shareholding pattern for informed investing decisions.

₹202.66

▲0.43%

as on 04:01PM, 29 Apr 2025

NSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Dishman Carbogen Amcis Ltd Performance

Get real-time share price information, day’s high and low, historical returns and market stats.

  • Day's Low

    Day's High

    ₹201.58
    Day's Price Range
    ₹206.92

  • 52 Week's Low

    52 Week's High

    ₹133
    52-Week Price Range
    ₹307.98
1 Month Return-3.79 %
3 Month Return-20.04 %
1 Year Return-10.09 %
Previous Close₹203.53
Open₹203.90
Volume2.03L
Upper Circuit-
Lower Circuit-
Market Cap₹3,197.59Cr

Dishman Carbogen Amcis Ltd Fundamentals & Key Indicators

Check the fundamental ratios and key indicators of the company like P/E, P/B, PEG, Dividend yield etc.

Market Cap

₹3,197.59 Cr

P/B Ratio

0.69

EPS (TTM)

1.15

Sector

Pharmaceuticals

How to invest in Dishman Carbogen Amcis Ltd

Investing in Dishman Carbogen Amcis Ltd is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Dishman Carbogen Amcis Ltd or DCAL on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

For example: You can buy 10 shares of Dishman Carbogen Amcis Ltd or start an SIP based on the market price on each investment date.

You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Dishman Carbogen Amcis Ltd with just a few clicks!

Dishman Carbogen Amcis Ltd Valuation

Track how the P/E of Dishman Carbogen Amcis Ltd has moved over time to understand valuation trends.

Dishman Carbogen Amcis Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-599.35x)

March 22, 2023

Today (-52.73x)

December 15, 2023

Industry (58.33x)

December 15, 2023

Highest (338.29x)

July 25, 2022

LowHigh

Today’s Price to Earnings Ratio: -52.73x

Analysts Forecast on Dishman Carbogen Amcis Ltd

Get share price movements and forecasts by analysts on Dishman Carbogen Amcis Ltd.

Excluding Excise Duty and Other Income, represents Net Revenue

Dishman Carbogen Amcis Ltd revenue growth forecast

Expected growth rate Q1, FY2023:-0.60%

Forecast

Actual

Source: S&P Global Market Intelligence

Dishman Carbogen Amcis Ltd Financials

Get the annual and quarterly financial summary of Dishman Carbogen Amcis Ltd, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ'2 23Q'3 23Q'4 23Q'1 24Q'2 24
Revenue₹723.38Cr (-)₹586.59Cr (↓18.91%)₹651.09Cr (↑11.00%)₹654.71Cr (↑0.56%)₹523.78Cr (↓20.00%)
Net Income₹17.00Cr (-)-₹40.90Cr (↓340.59%)-₹59.63Cr (↑45.79%)-₹69.92Cr (↑17.26%)-₹77.57Cr (↑10.94%)
Net Profit Margin2.35% (-)-6.97% (↓396.60%)-9.16% (↑31.42%)-10.68% (↑16.59%)-14.81% (↑38.67%)
Value in ₹ crore
Details2019202020212022
Total Assets₹5,862.79Cr (-)₹5,932.11Cr (↑1.18%)₹5,744.81Cr (↓3.16%)₹5,447.12Cr (↓5.18%)
Total Liabilities₹970.42Cr (-)₹1,136.26Cr (↑17.09%)₹1,070.19Cr (↓5.81%)₹1,215.34Cr (↑13.56%)
Value in ₹ crore
Details20182019202020212022
Operating Cash Flow₹20.06Cr (-)₹119.72Cr (↑496.81%)₹196.70Cr (↑64.30%)-₹1.51Cr (↓100.77%)₹227.35Cr (↓15,156.29%)

Dishman Carbogen Amcis Ltd Index Inclusions

BSE Healthcare

₹42,555.65

0 (▲0%)

BSE Small-Cap

₹48,193.46

0 (▲0%)

S&P BSE AllCap

₹10,471.31

0 (▲0%)

Dishman Carbogen Amcis Ltd Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Dishman Carbogen Amcis Ltd.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
59.32%
0.00
Foreign Institutions
9.34%
0.00
Mutual Funds
2.32%
0.00
Retail Investors
28.78%
0.00
Others
0.24%
0.00

Dishman Carbogen Amcis Ltd vs Peers

Compare market cap, revenue, PE, and other key metrics of Dishman Carbogen Amcis Ltd with its industry peers.

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
Dishman Carbogen Amcis Ltd
Dishman Carbogen Amcis Ltd
NA₹3,197.59 Cr34.5%0.57NANA
Kopran Ltd
Kopran Ltd
NA₹917.81 Cr113.16%0.55NANA
Makers Laboratories Ltd
Makers Laboratories Ltd
NA₹81.01 Cr41.61%0.64NANA
Decipher Labs Ltd
Decipher Labs Ltd
NA₹12.19 Cr-9.37%0.50NANA
Venus Remedies Ltd
Venus Remedies Ltd
BUY₹408.83 Cr182.55%0.55NANA
See all

Dishman Carbogen Amcis Ltd News & Key Events

Latest news and events at one place to help you take investing decisions in Dishman Carbogen Amcis Ltd.

  • Dishman Carbogen Secures Drug License, Shares Surge - 11 Apr, 2025

    Dishman Carbogen Amcis Ltd's subsidiary received a drug manufacturing license from NMPA in China, leading to significant share price increases of 5% and 10%. The company aims for revenue growth and improved EBITDA margins in the coming years.

  • Dishman Carbogen Amcis Secures Drug Manufacturing License in China - 09 Apr, 2025

    Dishman Carbogen Amcis Ltd's subsidiary, CARBOGEN AMCIS (Shanghai) Co. Ltd., has received a Drug Manufacturing License from China's NMPA, enabling regulatory-compliant manufacturing operations in Shanghai. This milestone enhances the company's international manufacturing capabilities.

  • Dishman Carbogen Amcis Allocates INR 50 Crore in Debentures - 26 Mar, 2025

    Dishman Carbogen Amcis Limited has allotted 5,000 non-convertible debentures worth INR 50 crore to raise capital through private placement, enhancing financial stability.

  • Dishman Carbogen Reports Growth and GMP Compliance - 20 Mar, 2025

    Dishman Carbogen Amcis Ltd's subsidiary received a GMP compliance certificate for its French site. The company reported a 4.8% increase in net sales for December 2024, with a substantial rise in net profit and EBITDA.

  • Dishman Carbogen Amcis Approves ₹50 Crore Debenture Issuance - 13 Mar, 2025

    Dishman Carbogen Amcis Ltd's shares increased by 1.90% following the board's approval for ₹50 crore in non-convertible debentures, enhancing liquidity and capital structure.

Insights on Dishman Carbogen Amcis Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 8.74% to 9.49% in Mar 2025 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 59.32% of holdings in Mar 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 51.1% return, outperforming this stock by 63.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 137.0% return, outperforming this stock by 113.5%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, DCAL stock has moved down by -7.7%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 33.09 Cr → 4.63 Cr (in ₹), with an average decrease of 86.0% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 795.69 Cr → 690.01 Cr (in ₹), with an average decrease of 13.3% per quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 30.51% to 29.93% in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 1.22% to 1.06% in Mar 2025 quarter

About Dishman Carbogen Amcis Ltd

Dishman Carbogen Amcis Ltd is a Gujarat, India based pharmaceutical manufacturing firm, listed on National Stock Exchange and Bombay Stock Exchange. It is the leading supplier of active pharmaceutical ingredients (API) for pharmaceutical and biotechnology companies, and a contract manufacturer for generic APIs, complex intermediates and custom synthesis products. The company is committed to deliver high quality and reliable products, as well as integrated services, including advanced process technology, cGMP manufacturing practices and project management. Dishman Carbogen Amcis has strong research and development capabilities with an in-depth knowledge of chemistry, established IP and access to world class facilities that enables faster delivery of cost effective products to global customers.

Revenue: ₹523.78Cr as on June 2024 (Q2 24)
Net Profit: ₹-77.57Cr as on June 2024 (Q2 24)
Listing date: 21 Sep, 2017
Chairperson Name: Janmejay R Vyas
OrganisationDishman Carbogen Amcis Ltd
HeadquartersGujarat
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Indian Mutual Funds that own Dishman Carbogen Amcis Ltd

Check out the Mutual Funds with significant holdings in Dishman Carbogen Amcis Ltd.

Futures and Options

View the latest movement in Dishman Carbogen Amcis Ltd Futures & Options, including strike prices, expiry dates, and percentage changes.

FAQs

What is Dishman Carbogen Amcis Ltd price today?

Dishman Carbogen Amcis Ltd share price today stands at ₹202.66, Open: ₹203.9, Previous Close: ₹203.53, High: ₹206.92, Low: ₹201.58, 52 Week High: ₹307.98, 52 Week Low: ₹133.

How to Buy Dishman Carbogen Amcis Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy Dishman Carbogen Amcis Ltd shares

What are today's traded volumes of Dishman Carbogen Amcis Ltd?

Today's traded volume of Dishman Carbogen Amcis Ltd(DCAL) is 2.03L.

What is today's market capitalisation of Dishman Carbogen Amcis Ltd?

Today's market capitalisation of Dishman Carbogen Amcis Ltd(DCAL) is ₹3,197.59 Cr.

What is the 52 Week High and Low Range of Dishman Carbogen Amcis Ltd?

Dishman Carbogen Amcis Ltd (DCAL)
Price
52 Week High
₹307.98
52 Week Low
₹133

How much percentage Dishman Carbogen Amcis Ltd is down from its 52 Week High?

Dishman Carbogen Amcis Ltd (DCAL) share price is ₹202.66. It is down -34.20% from its 52 Week High price of ₹307.98

How much percentage Dishman Carbogen Amcis Ltd is up from its 52 Week low?

Dishman Carbogen Amcis Ltd (DCAL) share price is ₹202.66. It is up 52.38% from its 52 Week Low price of ₹133